BURLESON & COMPANY, LLC – Bristol-Myers Squibb Company Transaction History
BURLESON & COMPANY, LLC portfolio value:
$2.19M
portfolio value
BURLESON & COMPANY, LLC quarter portfolio value change:
-7.68%
quarter
Bristol-Myers Squibb Company 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -0.02% | -7 shares | -183K | $71.09 | 30.84K |
| Q2 2022 | share | Increase | +0.04% | 13 shares | 124K | $77 | 30.85K |
| Q1 2022 | share | Increase | +0.66% | 203 shares | 342K | $73.03 | 30.84K |
| Q4 2021 | share | Decrease | -0.74% | -227 shares | 84K | $62.52 | 30.63K |
| Q3 2021 | share | Increase | +0.01% | 2 shares | -236K | $59.17 | 30.86K |
| Q2 2021 | share | Decrease | -0.02% | -5 shares | 113K | $65.79 | 30.86K |
| Q1 2021 | share | Increase | +0.01% | 3 shares | 34K | $62.15 | 30.86K |
| Q4 2020 | share | 0.00% | 0 shares | -54K | $60.6 | 30.86K | |
| Q3 2020 | share | Increase | +0.06% | 20 shares | 87K | $58 | 30.86K |
| Q2 2020 | share | Decrease | -0.86% | -266 shares | -17K | $56.14 | 30.84K |
| Q1 2020 | share | Increase | +0.25% | 77 shares | -194K | $52.79 | 31.11K |
| Q4 2019 | share | Increase | +1.47% | 450 shares | 418K | $60.36 | 31.03K |
| Q3 2019 | share | Increase | +0.17% | 53 shares | 295K | $47.3 | 30.58K |
| Q2 2019 | share | 0.00% | 0 shares | -104K | $41.93 | 30.53K | |
| Q1 2019 | share | Increase | +5.05% | 1.46K shares | 27K | $43.73 | 30.53K |
| Q4 2018 | share | Increase | +20.51% | 4.94K shares | 167K | $47.21 | 29.06K |
| Q3 2018 | share | Increase | +0.37% | 90 shares | -40K | $56.02 | 24.11K |
| Q2 2018 | share | Increase | +4.56% | 1.04K shares | -123K | $49.59 | 24.02K |
| Q1 2018 | share | Increase | +0.17% | 38 shares | 47K | $56.31 | 22.98K |
| Q4 2017 | share | Increase | 0.00% | 22.94K shares | 1.40M | $54.21 | 22.94K |